These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 2960700

  • 1. Oral enoximone pharmacokinetics in patients with congestive heart failure.
    Lima JJ, Leier CV, Holtz L, Sterechele J, Shields BJ, MacKichan JJ.
    J Clin Pharmacol; 1987 Sep; 27(9):654-60. PubMed ID: 2960700
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of intravenous enoximone in dialysis patients.
    Fiegel P, Trenk D, Jaehnchen E, Dieterich HA.
    J Cardiovasc Pharmacol; 1989 Sep; 14 Suppl 1():S20-3. PubMed ID: 2480480
    [Abstract] [Full Text] [Related]

  • 4. Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite.
    Okerholm RA, Chan KY, Lang JF, Thompson GA, Ruberg SJ.
    Am J Cardiol; 1987 Aug 14; 60(5):21C-26C. PubMed ID: 2956863
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of chronic cardiac insufficiency with intravenous bolus enoximone. Study of a pharmacokinetic-hemodynamic relation].
    Gibelin P, Garraffo R, Sbirrazzuoli V, Lapalus P, Morand P.
    Arch Mal Coeur Vaiss; 1990 Sep 14; 83 Spec No 3():75-81. PubMed ID: 2147839
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human serum and plasma protein binding of enoximone and its sulfoxide metabolite.
    Hook RH, Boxenbaum H, Thompson GA, Okerholm RA.
    J Pharm Sci; 1988 Dec 14; 77(12):1012-7. PubMed ID: 3244103
    [Abstract] [Full Text] [Related]

  • 8. A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure.
    Zipperle G, Butzer F, Dieterich HA, Heinrich F.
    Am J Cardiol; 1987 Aug 14; 60(5):72C-74C. PubMed ID: 2956873
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antiischemic and hemodynamic effects of an oral single dose of 150 mg of the phosphodiesterase inhibitor enoximone in patients with coronary artery disease--relation to plasma concentration.
    Mitrovic V, Petrovic O, Bahavar H, Neuzner J, Dieterich HA, Schlepper M.
    Cardiovasc Drugs Ther; 1991 Aug 14; 5(4):689-95. PubMed ID: 1832289
    [Abstract] [Full Text] [Related]

  • 11. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S, Uretsky BF, Betschart AR, Tokarczyk TR, Kolesar JA, Reddy PS.
    Am J Cardiol; 1990 Feb 15; 65(7):515-9. PubMed ID: 2137668
    [No Abstract] [Full Text] [Related]

  • 12. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K, Zannad F, Brunotte F, Belhadj K, Juilliere Y, Iannascoli F, Gilgenkrantz JM.
    Am J Cardiol; 1987 Aug 14; 60(5):75C-79C. PubMed ID: 2956874
    [Abstract] [Full Text] [Related]

  • 13. The relationship between pharmacokinetics and pharmacodynamics of enoximone in healthy man.
    Belz GG, Meinicke T, Schäfer-Korting M.
    Eur J Clin Pharmacol; 1988 Aug 14; 35(6):631-5. PubMed ID: 2976670
    [Abstract] [Full Text] [Related]

  • 14. Effects of low dose enoximone for chronic congestive heart failure.
    Jessup M, Ulrich S, Samaha J, Helfer D.
    Am J Cardiol; 1987 Aug 14; 60(5):80C-84C. PubMed ID: 2956875
    [Abstract] [Full Text] [Related]

  • 15. [Enoximone].
    Ventura G.
    Medicina (Firenze); 1990 Aug 14; 10(2):191-3. PubMed ID: 2148796
    [Abstract] [Full Text] [Related]

  • 16. A preliminary report of the effects of orally administered enoximone on regional hemodynamics in congestive heart failure.
    Leier CV, Meiler SE, Matthews S, Unverferth DV.
    Am J Cardiol; 1987 Aug 14; 60(5):27C-30C. PubMed ID: 2956864
    [Abstract] [Full Text] [Related]

  • 17. Electrophysiologic effects of enoximone in patients with congestive heart failure.
    Hohnloser SH, Zehender M, Geibel A, Meinertz T, Just H.
    J Cardiovasc Pharmacol; 1989 Aug 14; 14 Suppl 1():S29-32. PubMed ID: 2480482
    [Abstract] [Full Text] [Related]

  • 18. The effects of oral enoximone on cardiac performance, calf arterial blood flow, and constrictor effects of norepinephrine infused into hand veins in humans.
    Breithaupt K, Belz GG, Kempinski S, Schicketanz KH, Dieterich HA.
    J Cardiovasc Pharmacol; 1990 Sep 14; 16(3):349-53. PubMed ID: 1700203
    [Abstract] [Full Text] [Related]

  • 19. [Continuous enoximone infusion in patients with severe heart failure in dilated cardiomyopathy, hemodynamic, neurohumoral, chemical laboratory and clinical results].
    Neuzner J, Mitrovic V, Pitschner HF, Lissmann H, Schlepper M.
    Z Kardiol; 1991 Jun 14; 80(6):397-403. PubMed ID: 1681628
    [Abstract] [Full Text] [Related]

  • 20. Enoximone. A review of its pharmacological properties and therapeutic potential.
    Vernon MW, Heel RC, Brogden RN.
    Drugs; 1991 Dec 14; 42(6):997-1017. PubMed ID: 1724645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.